A medicines management SOP and controlled drugs procedure, drafted from your own rules
A medicines management SOP has to answer precise questions for a precise setting. Who may order, receive, administer, witness and destroy each kind of medicine. Where the controlled drugs cabinet is and who holds the keys. What the fridge range is, who logs it, and what happens when it goes out of range. A generic policy cannot answer those, and a wrong answer can hurt someone.
Name it a medicines management SOP, or a controlled drugs procedure, and INKFLOW works from guidance written for medicines and pharmacy procedures. It asks for your setting's own facts, from authorised roles and the register format to the cold chain and your lists of high-risk medicines.
A dose, threshold or time limit appears only if your material states it or an official source gives it; otherwise the draft marks the gap with a placeholder. The SOP is a draft for your clinical governance or approval route, with a sign-off page for your approvers. Responsibility for its clinical content stays with your registered professionals, and INKFLOW is independent and not affiliated with the NHS.
Drafting a medicines management SOP
- 1Fix the scopeOne setting and one service: a nursing home, a ward, a clinic or a community pharmacy. Say which medicines are covered and which are excluded.
- 2Name the rolesFor every step, who is authorised, who checks and who witnesses. A procedure that says a member of staff at a controlled drug step is not finished.
- 3Send the local rulesYour register format, stock-check routine, discrepancy rules, destruction process, high-risk and look-alike sound-alike lists, formulary and disposal arrangements.
- 4Route it for approvalPharmacy, nursing and your controlled drugs accountable officer, where you have one, approve it. Give it a number, a version and a review date.
What the medicines SOP guidance covers
Medicine names in a medicines management SOP
SOPs usually name medicines by their generic name. Some products are prescribed by brand for safety, such as certain modified-release preparations, where switching between brands can matter. Tell the writer about your formulary and any brand exceptions, so the draft does not tidy away a brand name that should stay.
The same applies to your lists of high-risk and critical medicines. They differ between organisations, so the draft uses yours rather than assuming one.